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Abstract
Background—Information about the harmful effects of vaping is sparse and inconsistent, 
therefore, since the use of electronic cigarettes (e-CIGs) has become increasingly popular as a tool 
to limit tobacco smoking, it is urgent to establish the safety or the toxicity of the liquid vaporized 
by the atomizer of the commercial e-CIGs.
Methods—Skin (HaCaT) and lung (A549) cells, the main targets of cigarette smoke, were 
exposed to e-CIG vapor (e-CIG Mini Touch T-Fumo T-TEX) and cigarette smoke (UK research 
cigarette) in a smoke chamber in vitro. The cytotoxic effect of the exposure was analyzed in both 
cell types by ultrastructural morphology, Trypan Blue exclusion test and LDH assay. In addition, 
pro-inflammatory cytokines were measured in culture medium by the Bio-Plex cytokine assay kit.
Results—The cytotoxic components of e-CIG were restrained to the flavoring compound and, to 
a lesser extent, to nicotine and their effects were comparable to that of cigarette smoke. 
Humectants alone exhibited no cytotoxicity but induced the release of cytokines and pro-
inflammatory mediators, mainly in keratinocytes.
Conclusions—Based on our results, we can state that e-CIG vapors exposure is not completely 
harmless, although far less toxic than CS. In fact, besides the deleterious effect of flavor and 
nicotine, even the humectants alone are able to evocate some adverse cellular events, such as 
enhanced cytokines release. This study will hopefully promote the development of truly innocuous 
e-CIGs to help people quit smoking.
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INTRODUCTION
Developed in China in 2004, the electronic cigarette (e-CIG) has become increasingly 
popular in numerous other countries. Marketers of the e-CIG describe it as an aid to help 
people quit smoking. They claim that while using an e-CIG simulates tobacco cigarette 
smoking, the odor and risks associated with tobacco smoke are eliminated as no combustion 
products and no tobacco toxins are inhaled [1].
In fact, in addition to variable doses of nicotine and different flavors, the base liquid 
typically includes propylene glycol (PG) and/or glycerol (also called vegetable glycerin or 
VG) and/or polyethylene glycol 400 (PEG400), all of which are widely used as additives in 
foods and personal care products, such as toothpaste [2].
Thus, the components of e-CIG vapors, inhaled in the act now called vaping, are assumed to 
be less harmful than the thousands of known and unknown toxicants in tobacco smoke. 
Nonetheless, this assumption does not entirely rule out potentially deleterious effects of 
inhaling the vapor of the nicotine/flavor mixture. Indeed, while The World Health 
Organization (WHO) has not excluded the e-CIG might be useful as a smoking cessation 
aid, it has stated that current research does not warrant the conclusion that the e-CIG is as 
safe and effective, in reducing nicotine-related withdrawal symptoms, as nicotine-
replacement patches or gum [3]. There is no specific legislation on the use of e-CIGs in 
Europe and currently member countries set their own regulations. Some countries, such as 
Belgium and Denmark, banned the sale of e-CIGs while Germany and Austria classified the 
e-CIG as a medical product. In the Netherlands, the use and purchase of e-CIGs is legal, but 
advertisement of them is banned. The European Union however, is currently debating 
banning all smokeless tobacco throughout Europe. Taking these products off the market 
however, would force thousands of users, who positively experienced vaping,[4] to return to 
cigarette smoking, with the known deleterious effects. Therefore, it is urgent to establish the 
safety or the toxicity of the components of the vapors from commercial e-CIGs in order to 
provide legislators, manufacturers and smokers with the essential scientific information 
required to make informed decisions. In the current study, we compared the in vitro 
cytotoxicity of cigarette smoke and e-CIG vapors on cells from lung and skin, the organs 
directly targeted by tobacco cigarettes.[5, 6]
Short term exposure of HaCaT cells (keratinocytes) and A549 cells (lung epithelial cells) to 
tobacco smoke and e-CIG vapors with and without aroma or nicotine were carried out. The 
results revealed that e-CIG vapors have some toxic effect on cell viability. In particular, the 
harmful component of the e-CIG seems to be restrained to the flavoring compounds rather 
than to nicotine and humectants. In addition, screening of an array of cytokines released 
from the cells exposed to e-CIG vapors without additives showed that the basal components 
alone are able to induce the release of several cytokines and pro-inflammatory mediators, 
suggesting the even humectants might have a potential, although non-cytotoxic, harmful 
effect.
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METHODS
Cell culture
HaCaT cells, (a gift from Dr. F. Virgili), were grown in Dulbecco's modified Eagle's 
medium High Glucose (Lonza, Milan, Italy), supplemented with 10% FBS, 100 U/ml 
penicillin, 100 μg/mL streptomycin and 2 mM L-glutamine. A549 cells were purchased 
from ATCC (Rockville, MD). Ham's F-12, foetal bovine serum, RPMI-1640, penicillin/
streptomycin and l-glutamine were obtained from Lonza (Milan, Italy). Cell suspension 
containing 5 × 106 viable cells/ml were used. Cells were incubated at 37 °C for 24 h in 95% 
air/5% CO2 until 80% confluency.
Cell viability
Viability studies were performed at different times after exposure by Trypan Blue exclusion 
test and LDH release assay. After Trypan blue staining, cells were counted by a cell counter 
(Invitrogen, Monza, Italy). Viable and nonviable cells were recorded separately, and the 
means of three independent counts were pooled for analysis and expressed as percent of died 
cells with respect to total cell number. The LDH release was measured by a two steps 
enzymatic assay. In the first step, NAD+ is reduced to NADH/H+ by the LDH-catalyzed 
conversion of lactate to pyruvate; in the second step, the catalyst (diaphorase) transfers H/H+ 
from NADH/H+ to tetrazolium salt which is reduced to formazan. The amounts of LDH in 
the culture medium were determined and calculated according to kit instructions (EuroClone 
Milan, Italy). Prior to each assay, the cells were lysed with 2% (V/V) Triton X-100 in 
culture media for 30 min at 37°C to obtain a representative maximal LDH release as the 
positive control with 100% toxicity All tests were performed in triplicate and assay was 
repeated three times independently with similar results.
CS and e-CIG exposure
Prior to CS and e-CIG exposure of the cells, medium was aspirated and fresh serum-free 
medium was added. Cells were then exposed for 50 min to CS and e-CIG mixture. Control 
cells were exposed to filtered air for the same duration (50 min) after changing media. The 
time and the method of exposure were chosen based on our previous works.[5,7]
HaCaT cells were exposed to fresh CS in an exposure system that generated CS by burning 
one UK research cigarette (12 mg tar, 1.1 mg nicotine), and to e-CIG mixtures (balsamic 
flavours with or without nicotine, Cloudsmoke, Terna Trade) using a vacuum pump to draw 
air through the cigarette and leading the smoke stream over the cell cultures as described 
previously by our group.[5,7] After the exposure (air or CS, e-CIG), fresh media 
supplemented with 10% FBS was added to the cells.
Ultrastructural study
After CS exposure, HaCaT and A549 cells (1 x 106 cell/ml) were scraped and collected in 
0.1M cacodylate buffer (pH 7.4), then spun in 1.5ml tubes at 2000×g for 5 min. Pellets were 
fixed with 2.5% glutaraldehyde in 0.1M sodium cacodylate buffer for 4 h at 4 C. They were 
then washed with 0.1M cacodylate buffer (pH 7.4) three times and post-fixed in 1% osmium 
tetroxide and 0.1M cacodylate buffer at pH 7.4 for 1 h at room temperature. The specimens 
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were dehydrated in graded concentrations of ethanol and embedded in epoxide resin (Agar 
Scientific, 66A Cambridge Road, Stanstead Essex, CM24 8DA, UK). Cells were then 
transferred to latex modules filled with resin and subsequently thermally cured at 60 C for 
48 h. Semi-thin sections (0.5-1 m thickness) were cut using an ultra-microtome (Reichard 
Ultracut S, Austria) stained with toluidine blue, and blocks were selected for thinning. Ultra-
thin sections of about 40-60 nm were cut and mounted onto formvar-coated copper grids. 
These were then double-stained with 1% uranyl acetate and 0.1% lead citrate for 30 min 
each and examined under a transmission electron microscope, Hitachi H-800 (Tokyo, 
Japan), at an accelerating voltage of 100 KV.
Cytokine Assay
Cytokines released in culture medium by HACAT and A549 cells were measured by Bio-
Plex cytokine assay (Bio-Rad Laboratories, Hercules, CA) as described elsewhere.[8, 9]
The Bio-Plex cytokine assay is designed for the multiplexed quantitative measurement of 
multiple cytokines in a single well using as little as 50 μl of sample. In our experiments, we 
used the premixed multiplex beads of the Bio-Plex human cytokine Human 27-Plex Panel 
(Bio-Rad, Cat. n.o. 171-A11127), which included twenty-seven cytokines [IL-1b; IL-1ras, 
IL-2, IL-4, Il-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-10, IL-12 (P70), IL-13, IL-15, IL-17, Basic 
FGF, Eotaxin, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1, IP -1 (MCAF), MIP-1α, MIP-1β, 
PDGF-BB, RANTES, TNF-α, VEGF]. Briefly, 50 μl of cytokine standards or samples 
(supernatants from treated cells) were incubated with 50 μl of anti-cytokine conjugated 
beads in 96-well filter plates for 30 min at room temperature with shaking. Plates were then 
washed by vacuum filtration three times with 100 μl of Bio-Plex wash buffer, 25 μl of 
diluted detection antibody was added, and plates were incubated for 30 min at room 
temperature with shaking. After three filter washes, 50 μl of streptavidinphycoerythrin was 
added, and the plates were incubated for 10 min at room temperature with shaking. Finally, 
plates were washed by vacuum filtration three times, beads were suspended in Bio-Plex 
assay buffer, and sample were analyzed on Bio-Rad 96 plate reader using the Bio-Plex 
suspension array system and Bio-Plex manager software(Bio-Rad Laboratories, Hercules, 
CA).
Statistical analysis
Values are expressed as the mean±SD values from at least three independent experiments. 
Student's t was used to determine statistical significance with a threshold of p values less 
than 0.05.
RESULTS
LDH release and viability
As shown in Fig.1A and Fig.2A respectively, HaCaT and A549 cells viability does not 
change in controls over 24 h and, consistently, a steady low release of LDH was observed 
(Fig.3A and Fig.4A). In contrast, exposure to CS caused an early (6 h) and progressive 
decrease in cell viability (Fig.1B and Fig.2B) and increased LDH release (Fig.3B and Fig.
4B) with a similar trend during the different time points in both cell lines, although 
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keratinocytes seem to be more susceptible to CS induced toxicity after 24hr (Fig.4B). 
Exposure to e-CIG vapor in which both flavoring substances and nicotine were absent 
resulted in no change in either cell viability (Fig 1C and Fig 2C) or LDH release (Fig.3C and 
Fig.4C) over 24 h. In stark contrast to e-CIG without the additives, exposure to e-CIG with 
flavor caused significant progressive loss of viability (Fig.1D and Fig.2D) and increased 
LDH release (Fig.3D and Fig.4D) in both cell types. Even more dramatically, e-CIG with 
flavoring and nicotine caused rapid (50 min) and marked loss in viability (Fig.1E and Fig.
2E) and enhanced LDH release (Fig.3E and Fig.4E), exhibiting a quantitative and qualitative 
response superimposable to that of CS exposure.
Cellular morphology
Results from TEM are in line with the viability and toxicity data. As shown in Fig.5, in 
control conditions, the utrastructural appearance is unchanged after both 50 minutes (T0) 
and 24 hours (T24); cells appear closely adherent and cellular organelles and mitochondria 
are well defined in both cell types. The morphology of the cells exposed to CS shows clear 
signs of cellular damage and presence of vacuoles. Once the cells were exposed to e-CIG 
with flavors it is possible to observe an increase in vacuolization and alteration of 
cytoplasmic membrane. The degeneration of intracellular organelles is worsened in the 
presence of flavors plus nicotine and particularly evident in HaCaT cells, with a marked 
vacuolization consequent to the expansion of the mitochondria and the endoplasmic 
reticulum. The cells treated with e-CIG without nicotine and flavors (humectants alone), 
remained intact with the same ultrastructural aspect of control cells, even 24 hours after 
treatment.
Cytokine release
Despite the lack of cytotoxicity of the basal component of e-CIG vapors, a possible irritant/
inflammatory effect could not be excluded. Therefore, we performed a quantitative 
measurement using the Bio-plex technology [8, 9] of multiple cytokines released by both 
keratynocytes and lung cells after vapors exposure. The results concerning the released 
cytokines/chemokines displaying concentrations ≥ 5 pg/ml in both HaCaT and A549 cells 
were taken in consideration in order to mimimize the background, and are reported in Table 
1. As expected, the pattern of cytokine/chemokine release is different in the two cell lines. 
Interestingly, increases of cytokine/chemokine release (≥ 1.2 fold) was found in the two cell 
lines when PDGF-BB, basic FGF, IL-8, Il-12, IL-17, GM-CSF, IP-10, MCP-1 and MIP-1β 
were analyzed. Increased release of IL-1rα, IL-10, G-CSF, IFN-γ, RANTES, TNF-α and 
VEGF was found only in HaCaT. IL-6 release decreased both in HaCaT and A549 cells. The 
highest increase in HaCaT cells (≥ 8 fold) was that of IL-8 (11.9 fold) and IP-10 (13.7 fold). 
The highest increase in A479 cells was that of basic FGF (9.9 fold). These results indicate 
that the basal components of e-CIG vapor, although non-toxic, contain some pro-
inflammatory stimuli leading to a changes in the secretome pattern depending from the 
employed cells lines. We also found fluctuations in cytokines release after other e-CIG and 
CS exposures but, because of the concomitant cell death, interpretation of such changes as 
active release or loss due to cell disruption was not possible (data not shown).
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DISCUSSION
Although there have been few studies suggestive of harmful effects from vaping, the results 
thus far have been inconsistent. This is likely due to a lack of standardized assessment, but 
also to varying chemical composition of commercial refill fluids among brands. A recent 
study showed that using an e-CIG for 5 min has immediate adverse physiologic effects 
similar to those seen with tobacco smoking.[10] In another recent study, where serum 
cotinine, lung function, exhaled carbon monoxide and nitric oxide were assessed and 
compared between e-CIG users and tobacco cigarette smokers, the results showed that e-
CIGs generated smaller changes in lung function but had a nicotinergic impact similar to 
that from tobacco cigarettes.[11] Although it is generally believed that the diseases caused 
by smoking are more likely caused by products of combustion rather than by nicotine, 
nicotine inhalation through e-CIGs can be completely avoided by simply using nicotine-free 
cartridges. Our results are in agreement with the study by Bahl et al. performed in vitro on 
embryonic and adult cells who found that cytotoxicity was not due to nicotine or 
humectants, but was correlated with the number and concentration of chemicals used to 
flavor fluids[12]. Nevertheless, the absence of cytotoxicity of humectants on skin and lung 
cells does not exclude possible harmful effects on other cell populations, such as pulmonary 
macrophages, especially after long term exposure. Indeed, an isolated case of lipoid 
pneumonia associated with vaping and ascribed to the glycerin vapors has been reported in a 
42-years-old woman who had used e-CIGs for about 7 months [13]. On the other hand, 
glycerin and propylene glycol are commonly used as humectants also in tobacco cigarettes, 
to prevent excessive drying of the tobacco filler and in water pipe tobacco, to increase 
smoke development. In a previous in vivo study, performed in a rat model, the addition of 
glycerin and propylene glycol to tobacco cigarettes was found do not significantly affect the 
toxicity of smoke inhaled for 13 weeks.[14] However, despite the likely safety of 
humectants, the presence of silicate particles and metal elements, which have been recently 
found in vapours from an e-CIG leading brand, may have some cytotoxic effects.[15] The 
authors of this last study recommend the manufacturers high selection of the materials used 
in e-CIGs and stringent quality control procedures, since the metals are thought to derive 
from the cartomizer (atomizer and cartridge), rather than from the fluid. A comparative 
study on the effects of e-CIG vapor and cigarette smoke on indoor air quality,[16] provided 
evidence that vaping is safer than smoking and that “secondhand” vapor is much less 
dangerous than secondhand smoke.[17] Cahn and Siegel provided a table of the components 
of several brands of e-CIGs.[18] While some of the components other than flavoring agents 
and nicotine are generally regarded as safe, including propylene glycol and glycerin, 
information on some components does not clearly rule out potential toxicity. Although the 
present results and the bulk of the literature indicate that e-CIG without additives are likely 
devoid of cytotoxicity, such results probably underestimated their whole harmful potential 
since toxicity tests do not routinely evaluate possible inflammatory and irritant effects of 
vaping. The current study showed, for the first time, that a panel of pro-inflammatory 
cytokines/chemokines (PDGF-BB, basic FGF, IL-8, Il-12, IL-17, GM-CSF, IP-10, MCP-1 
and MIP-1β) are increasingly released into the medium, following exposure to e-CIG vapors 
without additives, by keratynocytes and lung cells, indicating that even the non-cytotoxic 
components of e-CIG might have a potential dangerous effect. The release of other 
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cytokines, such as IL-1rα, IL-10, G-CSF, IFN-γ, RANTES, TNF-α and VEGF instead 
increased only in the keratinocyte cell line. We don't know whether all e-CIGs contain 
inflammatory stimuli, but it would be prudent if such studies were carried out while the use 
of e-CIGs is becoming more common so that brands can be developed that are truly 
innocuous. Moreover, the experimental system employed might be useful to identify 
molecules able to decrease the pro-inflammatory effects of eCIG. Interestingly, for each 
brand a differential chemical strategy to block pro-inflammatory effects might be proposed.
What this paper adds
In closing, our results indicate that e-CIGs are illusively safety, although they are far less 
noxious than tobacco cigarettes, thus the ideal remains that people should stop both smoking 
and vaping. In fact even the only vaping is able to stimulate cytokines release that play a 
role in inflammation. Nevertheless, this study also suggests that, if the refill accessories are 
properly chosen, vaping could be a safer alternative to smoking for smokers who are unable 
or unwilling to stop.
Acknowledgments
The authors thank Marangoni's Pharmacy, Argenta, Italy for the kind gift of e-CIG Mini Touch T-Fumo T-TEX srl.
Funding HJF is supported by NIH grant ES020942.
REFERENCES
1. Caponnetto P, Campagna D, Papale G, et al. The emerging phenomenon of electronic cigarettes. 
Expert Rev Respir Med. 2012; 6(1):63–74. [PubMed: 22283580] 
2. Fluhr JW, Darlenski R, Surber C. Glycerol and the skin: holistic approach to its origin and 
functions. Br J Dermatol. 2008; 159(1):23–34. [PubMed: 18510666] 
3. Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement 
therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract. 2013; 
8(1):5. [PubMed: 23497603] 
4. Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-CIGarettes versus nicotine replacement 
therapy among successful e-CIGarette users: a qualitative approach. Addict Sci Clin Pract. 2013; 
8:5. [PubMed: 23497603] 
5. Sticozzi C, Belmonte G, Pecorelli A, et al. Cigarette smoke affects keratinocytes SRB1 expression 
and localization via H2O2 production and HNE protein adducts formation. PLoS One. 2012; 
7:e3359.
6. Valacchi G, Davis PA, Khan EM, et al. Cigarette smoke exposure causes changes in Scavenger 
Receptor B1 level and distribution in lung cells. Int J Biochem Cell Biol. 2011; 43:1065–1070. 
[PubMed: 19497383] 
7. Sticozzi C, Pecorelli A, Belmonte G, et al. Cigarette Smoke Affects ABCAl Expression via Liver X 
Receptor Nuclear Translocation in Human Keratinocytes. Int J Mol Sci. 2010; 11:3375–3386. 
[PubMed: 20957101] 
8. Borgatti M, Rizzo R, Canto MB, et al. Release of sICAM-1 in oocytes and in vitro fertilized human 
embryos. PLoS One. 2008; 3:e3970. [PubMed: 19092999] 
9. Gambari R, Borgatti M, Lampronti I, et al. Corilagin is a potent inhibitor of NF-kappaB activity and 
downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells. Int 
Immunopharmacol. 2012; 13:308–315. [PubMed: 22561123] 
10. Vardavas CI, Anagnostopoulos N, Kougias M, et al. Short-term pulmonary effects of using an 
electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. 
Chest. 2012; 141:1400–1406. [PubMed: 22194587] 
Cervellati et al. Page 7
Toxicol In Vitro. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
11. Flouris AD, Chorti MS, Poulianiti KP, et al. Acute impact of active and passive electronic cigarette 
smoking on serum cotinine and lung function. Inhal Toxicol. 2013; 25:91–101. [PubMed: 
23363041] 
12. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid 
cytotoxicity using embryonic and adult models. Reprod Toxicol. 2012; 34:529–537. [PubMed: 
22989551] 
13. McCauley L, Markin M, Hosmer D. An Unexpected Consequence of Electronic Cigarette Use. 
Chest. 2012; 141:1110–1113. [PubMed: 22474155] 
14. Heck JD, Gaworski CL, Rajendran N, et al. Toxicologic evaluation of humectants added to 
cigarette tobacco: 13-week smoke inhalation study of glycerin and propylene glycol in Fischer 344 
rats. Inhal Toxicol. 2002; 14:1135–1152. [PubMed: 12454795] 
15. Williams M, Villarreal A, Bozhilov K, et al. Metal and Silicate Particles Including Nanoparticles 
Are Present in Electronic Cigarette Cartomizer Fluid and Aerosol. PLoS One. 2013; 8:e57987. 
[PubMed: 23526962] 
16. McAuley TR, Hopke PK, Zhao J, et al. Comparison of the effects of e-cigarette vapor and cigarette 
smoke on indoor air quality. Inhal Toxicol. 2012; 24:850–857. [PubMed: 23033998] 
17. Guingab-Cagmat J, Bauzo RM, Bruijnzeel AW, et al. Methods in tobacco abuse: proteomic 
changes following second-hand smoke exposure. Methods Mol Biol. 2012; 829:329–348. 
[PubMed: 22231825] 
18. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: A step 
forward or a repeat of past mistakes? J Public Health Policy. 2011; 32:16–31. [PubMed: 
21150942] 
Cervellati et al. Page 8
Toxicol In Vitro. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1. 
Cytotoxicity measured as LDH release in HaCaT cells after exposure to air (A), cigarette 
smoke (B), electronic cigarette with nicotine (C), electronic cigarette with flavor (D) and 
only vaping (E). Triton X represent 100% of LDH release. Data are expressed as percentage 
of control (averages of five different experiments), *p < 0.05).
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Figure 2. 
Cytotoxicity measured as LDH release in A549 cells after exposure to air (A), cigarette 
smoke (B), electronic cigarette with nicotine (C), electronic cigarette with flavor (D) and 
only vaping (E). Triton X represent 100% of LDH release. Data are expressed as percentage 
of control (averages of five different experiments), *p < 0.05).
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Figure 3. 
Cell viability in HaCaT cells after exposure to air (A), cigarette smoke (B), electronic 
cigarette with nicotine (C), electronic cigarette with flavor (D) and only vaping (E). Data are 
expressed as percentage of control (averages of five different experiments), *p < 0.05).
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Figure 4. 
Cell viability in A549 cells after exposure to air (A), cigarette smoke (B), electronic 
cigarette with nicotine (C), electronic cigarette with flavor (D) and only vaping (E). Data are 
expressed as percentage of control (averages of five different experiments), *p < 0.05).
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Figure 5. 
Ultrastructural study of A549 cells (left column) and HaCaT cells (right column) after 
exposure to different conditions at T0 (immediately after the exposure) and T24 (24 hr after 
the exposure. Bars = 2 μm.
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Table 1
Cytokine/chemokine concentrations in culture medium from untreated (control) and vapor exposed (e-cig) 
HaCat and A549 cells
HaCat A549
Control (pg/ml) e-cig (pg/ml) Control (pg/ml) e-cig (pg/ml)
Hu PDGF-BB 58.4 220.1 3.8 6.72 30.4 4.5
Hu basic FGF 31.6 64.7 2.0 24.4 240.8 9.9
Hu IL-1ra 49.7 157.7 3.18 41.1 32.7 0.8
Hu IL-6 1336.8 1002.6 0.8 6779.5 2704.12 0.4
Hu IL-8 504.5 6017.1 11.9 1135.8 1639.2 1.4
Hu IL-10 6.1 15.1 2.5 5.6 5.5 1.0
Hu IL-12 40.5 62.87 1.5 26.9 37.4 1.4
Hu IL-17 34.6 47.6 1.4 5.4 9.3 1.7
Hu G-CSF 12.9 125.7 9.7 11.5 12.6 1.1
Hu GM-CSF 23.3 50.6 2.2 7.4 12.9 1.7
Hu IFN-γ 57.1 188.5 3.3 61.3 50.3 0.8
Hu IP-10 245.3 3375.1 13.7 24.8 32.5 1.3
Hu MCP-1 470.4 1103.3 2.3 1437.3 2505.6 1.74
Hu MIP-1β 20.6 41.8 2.0 5.7 10.1 1.8
RANTES 2487.2 2905.1 1.2 229.5 231.2 1.0
Hu TNF-α 10.2 35.1 3.4 12.3 8.8 0.7
Hu VEGF 3829.6 11689.1 3.1 3046.1 3488.1 1.1
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